IA
IFS Advisors Portfolio holdings
AUM
$132M
This Quarter Return
-4.04%
1 Year Return
+10.07%
3 Year Return
+47.16%
5 Year Return
–
10 Year Return
–
AUM
$123M
AUM Growth
+$123M
(-3.2%)
Cap. Flow
+$1.51M
Cap. Flow
% of AUM
1.23%
Top 10 Holdings %
Top 10 Hldgs %
95.12%
Holding
205
New
17
Increased
34
Reduced
9
Closed
6
Top Buys
| 1 |
iShares 0-3 Month Treasury Bond ETF
SGOV
|
$858K |
| 2 |
iShares Core Dividend Growth ETF
DGRO
|
$152K |
| 3 |
Cardinal Health
CAH
|
$143K |
| 4 |
Vanguard Mid-Cap ETF
VO
|
$134K |
| 5 |
Innovator Uncapped Accelerated US Equity ETF
XUSP
|
$75.6K |
Top Sells
| 1 |
Vanguard Information Technology ETF
VGT
|
$180K |
| 2 |
iShares Core S&P 500 ETF
IVV
|
$119K |
| 3 |
iShares Russell 1000 ETF
IWB
|
$19.9K |
| 4 |
Vanguard S&P 500 ETF
VOO
|
$11.8K |
| 5 |
iShares Russell 1000 Growth ETF
IWF
|
$10.5K |
Sector Composition
| 1 | Technology | 0.91% |
| 2 | Financials | 0.78% |
| 3 | Healthcare | 0.46% |
| 4 | Energy | 0.38% |
| 5 | Consumer Staples | 0.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Dare Bioscience
DARE
$27.4M
| $2.75K | ﹤0.01% |
950
| – | – |
|
152
JPMorgan Chase
JPM
$824B
| $2.74K | ﹤0.01% |
11
| – | – |
|
153
Gilead Sciences
GILD
$140B
| $2.69K | ﹤0.01% |
23
| – | – |
|
154
ASML
ASML
$285B
| $2.65K | ﹤0.01% |
+4
| New | +$2.65K |
|
155
Corteva
CTVA
$50.2B
| $2.33K | ﹤0.01% |
+37
| New | +$2.33K |
|
156
Warner Bros
WBD
$28.8B
| $2.2K | ﹤0.01% |
205
| – | – |
|
157
Cisco
CSCO
$268B
| $2.17K | ﹤0.01% |
35
| – | – |
|
158
Target
TGT
$42B
| $2.09K | ﹤0.01% |
20
| – | – |
|
159
CRISPR Therapeutics
CRSP
$4.79B
| $2.01K | ﹤0.01% |
+59
| New | +$2.01K |
|
160
iShares China Large-Cap ETF
FXI
$6.71B
| $1.97K | ﹤0.01% |
55
| – | – |
|
161
Cloudflare
NET
$72.5B
| $1.92K | ﹤0.01% |
+17
| New | +$1.92K |
|
162
SentinelOne
S
$5.9B
| $1.82K | ﹤0.01% |
100
| – | – |
|
163
Andersons Inc
ANDE
$1.39B
| $1.8K | ﹤0.01% |
42
| – | – |
|
164
Nike
NKE
$110B
| $1.78K | ﹤0.01% |
28
| – | – |
|
165
PayPal
PYPL
$66.2B
| $1.63K | ﹤0.01% |
25
-25
| -50% | -$1.63K |
|
166
Arm
ARM
$140B
| $1.6K | ﹤0.01% |
+15
| New | +$1.6K |
|
167
Moderna
MRNA
$9.41B
| $1.56K | ﹤0.01% |
55
| – | – |
|
168
Purple Innovation
PRPL
$118M
| $1.46K | ﹤0.01% |
1,921
| – | – |
|
169
Corning
GLW
$58.7B
| $1.37K | ﹤0.01% |
30
| – | – |
|
|
XYZ
170
Block, Inc.
XYZ
$46.5B
| $1.36K | ﹤0.01% |
+25
| New | +$1.36K |
|
171
Prudential Financial
PRU
$37.8B
| $1.34K | ﹤0.01% |
12
| – | – |
|
172
Kyndryl
KD
$7.21B
| $1.32K | ﹤0.01% |
42
| – | – |
|
173
Rivian
RIVN
$16.8B
| $1.25K | ﹤0.01% |
100
| – | – |
|
174
Compass Minerals
CMP
$793M
| $1.11K | ﹤0.01% |
120
| – | – |
|
175
Innovative Industrial Properties
IIPR
$1.53B
| $1.08K | ﹤0.01% |
20
| – | – |
|